News & Updates

Show Multimedia Only

Bexicaserin shows promise in developmental and epileptic encephalopathies

08 Nov 2025

In the treatment of patients with developmental and epileptic encephalopathies (DEEs), the selective serotonin 5-HT2C receptor agonist bexicaserin is well tolerated and appears to reduce the frequency of countable motor seizures, according to a phase Ib/IIa study.

Bexicaserin shows promise in developmental and epileptic encephalopathies

08 Nov 2025

Long-term LVEF decline occurs following COVID-19

08 Nov 2025 by

Individuals with SARS‐CoV‐2 infection, especially those who are hospitalized, face long‐term declines in left ventricular ejection fraction (LVEF), according to a retrospective study.

Long-term LVEF decline occurs following COVID-19

08 Nov 2025

High plasma triglycerides protect patients with PD against cognitive impairment

08 Nov 2025

In patients with Parkinson’s disease (PD), the high risk of mild cognitive impairment (MCI) at the time of diagnosis correlates with low levels of plasma triglycerides (P-TG) and an interaction between change in BMI and P-TG prior to diagnosis, reports a study.

High plasma triglycerides protect patients with PD against cognitive impairment

08 Nov 2025

Frailty linked to increased AF-related hospitalizations in seniors

08 Nov 2025

Older adults with frailty are predisposed to atrial fibrillation (AF)-related hospitalizations, regardless of the presence of multimorbidity, according to a study.

Frailty linked to increased AF-related hospitalizations in seniors

08 Nov 2025

Night light exposure ups cardiovascular risk

07 Nov 2025

Individuals exposed to brighter lights at night have increased risks of incident coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke, according to a study.

Night light exposure ups cardiovascular risk

07 Nov 2025

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

07 Nov 2025 by

For patients who are struggling to lose weight after metabolic bariatric surgery, treatment with liraglutide boosts weight-loss outcomes and helps avoid conversion surgery, as shown in a randomized clinical trial.

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

07 Nov 2025

PREVENT equations identify individuals who will benefit from intensive SBP control

07 Nov 2025

The reduction in relative risk with intensive vs standard systolic blood pressure (SBP) treatment among individuals without baseline cardiovascular disease (CVD) is consistent across the risk strata using the PREVENT* equations, as shown in the SPRINT study.

PREVENT equations identify individuals who will benefit from intensive SBP control

07 Nov 2025

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

07 Nov 2025 by

The use of bemarituzumab in combination with chemotherapy provides statistically significant survival benefits among patients with advanced or metastatic FGFR2b-overexpressing gastric or gastroesophageal junction cancer (G/GEJC) in the primary analysis of the phase III FORTITUDE-101 trial.

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

07 Nov 2025

Breastfeeding improves health outcomes in mothers, children

07 Nov 2025

Breastfeeding provides several benefits to mothers and their children, including reduced risks in sudden infant death syndrome and allergic rhinitis, as well as improved physical fitness, reports a study.

Breastfeeding improves health outcomes in mothers, children

07 Nov 2025

Retinal ageing marker may predict cognitive decline, dementia

07 Nov 2025 by

A study from Singapore underscores the potential of a retinal ageing biomarker derived from retinal photography as a prognostic biomarker for cognitive decline and incident dementia.

Retinal ageing marker may predict cognitive decline, dementia

07 Nov 2025

News & Updates

Filter by Specialty:

Specialty:

Bexicaserin shows promise in developmental and epileptic encephalopathies

Bexicaserin shows promise in developmental and epileptic encephalopathies

Long-term LVEF decline occurs following COVID-19

Long-term LVEF decline occurs following COVID-19

High plasma triglycerides protect patients with PD against cognitive impairment

High plasma triglycerides protect patients with PD against cognitive impairment

Frailty linked to increased AF-related hospitalizations in seniors

Frailty linked to increased AF-related hospitalizations in seniors

Night light exposure ups cardiovascular risk

Night light exposure ups cardiovascular risk

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

PREVENT equations identify individuals who will benefit from intensive SBP control

PREVENT equations identify individuals who will benefit from intensive SBP control

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

Bemarituzumab extends survival in FGFR2b-overexpressing gastric cancer

Breastfeeding improves health outcomes in mothers, children

Breastfeeding improves health outcomes in mothers, children

Retinal ageing marker may predict cognitive decline, dementia

Retinal ageing marker may predict cognitive decline, dementia